Clinical trial
Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery
NCT07178639 is registered in ClinicalTrials.gov with Nemocnice Kolín as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery
- Lead sponsor
- Nemocnice Kolín
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2025
- Completion date
- February 28, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cataract surgery, macular oedema, nsaid (non-steroidal anti-inflammatory drug)